Company
Definium Therapeutics, Inc. (DFTX)
Standardized SEC financial data for Definium Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001813814 · NASDAQ · Medicinal Chemicals & Botanical Products.
Return on equity
-55.3%
ROIC
-114.2%
Free cash flow
-$131.6M
Debt / equity
0.12×
Current ratio
6.29×
EPS (diluted)
$-2.06
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $18.6M | $34.8M | $36.2M | $52.1M | $65.3M | $117.7M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $80.1M | $133.5M | $142.1M | $99.7M | $273.7M | $257.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.6M | -$45.8M | -$50.1M | -$64.4M | -$79.1M | -$131.6M |
| Investing cash flow |
Get DFTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/DFTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/DFTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"